| Market Cap | ₹9,376Cr |
| ROE | 49.51% |
| P/E Ratio(TTM) | 30.56 |
| EPS(TTM) | 184.83 |
| P/B Ratio | 15.13 |
| Dividend Yield | 2.21% |
| Industry P/E | 39.69 |
| Book Value | 373.34 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Procter & Gamble Health Limited |
| Managing Director | Mr. Milind Thatte |
| Founded | 1967 |
| NSE Symbol | PGHL |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 39.49 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 44.95 | ||
| Pfizer | NA (0.00%) | 27.79 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.76 |